Evidence for successful implementation of exposure and response prevention in a naturalistic group format for pediatric OCD

Depression and Anxiety

Volumn 28, Issue 4, 2011, Pages 342-348

  Olino, Thomas M ^a   Gillo, Susan ^a   Rowe, David ^a   Palermo, Sean ^a   Nuhfer, Elizabeth C ^a   Birmaher, Boris ^a   Gilbert, Andrew R ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Naturalistic study; OCD; Treatment

Indexed keywords

ADOLESCENT; ANXIETY; ARTICLE; CHILD; CLINICAL ARTICLE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH PROGRAM; HUMAN; MENTAL DISEASE; MOOD; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

ADOLESCENT; AMBULATORY CARE; ANXIETY DISORDERS; CHILD; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; EVIDENCE-BASED PRACTICE; FAMILY THERAPY; FEMALE; HUMANS; IMPLOSIVE THERAPY; INDIVIDUALITY; INHIBITION (PSYCHOLOGY); MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTHERAPY, GROUP; TREATMENT OUTCOME;

EID: 79953750628     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20789     Document Type: Article

References (27)

1. POTS. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. J Am Med Assoc 2004;292:1969-1976.
2. Abramowitz JS, Whiteside SP, Deacon BJ. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther 2005;36:55-63. (Pubitemid 43150332)
3. Watson HJ, Rees CS. Meta-analysis of randomized, controlled treatment trials for pediatric Obsessive-Compulsive Disorder. J Child Psychol Psychiatry 2008;49:489-498. (Pubitemid 351503099)
4. AACAP. Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998;37:27S-45S.
5. Bolton D, Perrin S. Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. J Behav Ther Exp Psychiatry 2008;39:11-22. (Pubitemid 350236108)
6. Masi G, Millepiedi S, Mucci M, Bertini N, Milantoni L, Arcangeli F. A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2005;44:673-681. (Pubitemid 40875362)
7. Storch EA, Bagner DM, Geffken GR, Adkins JW, Murphy TK, Goodman WK. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety 2007;24:375-381. (Pubitemid 47606145)
8. Krebs G, Heyman I. Treatment-resistant obsessive-compulsive disorder in young people: assessment and treatment strategies. Child Adolesc Ment Health 2010;15:2-11.
9. Storch EA, Geffken GR, Merlo LJ, et al. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007;46:469-478. (Pubitemid 46622755)
10. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 2008;359:2753-2766.
11. Grados M, Riddle MA. Do all obsessive-compulsive disorder subtypes respond to medication? Int Rev Psychiatry 2008;20:189-193.
12. Stewart SE, Rosario MC, Brown TA, et al. Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biol Psychiatry 2007;61:285-291. (Pubitemid 46108692)
13. Landeros-Weisenberger A, Bloch MH, Kelmendi B, et al. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord 2010;121:175-179.
14. Masi G, Millepiedi S, Perugi G, et al. Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. CNS drugs 2009;23:241-252.
15. Flament MF, Rapoport JL, Berg CJ, et al. Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Arch Gen Psychiatry 1985;42:977-983.
16. Ginsburg GS, Kingery JN, Drake KL, Grados MA. Predictors of treatment response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008;47:868-878.
17. Storch EA, Merlo LJ, Larson MJ, et al. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008;47:583-592. (Pubitemid 351591608)
18. Wagner AP. Treatment of OCD in Children and Adolescents: A Cognitive-Behavioral Therapy Manual. USA: Lighthouse Press, Inc; 2003.
19. Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997;36:844-852. (Pubitemid 27250450)
20. Rosario-Campos MC, Miguel EC, Quatrano S, et al. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry 2006;11:495-504.
21. Birmaher B, Khetarpal S, Brent D, et al. The screen for child anxiety related emotional disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 1997;36:545-553. (Pubitemid 27149193)
22. Messer SC, Angold A, Costello EJ, Loeber R. Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents: factor composition and structure across development. Int J Methods Psychiatr Res 1995;5:251-262. (Pubitemid 126764714)
23. Costello EJ, Angold A. Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry 1988;27:726-737. (Pubitemid 19003712)
24. Muthén LK, Muthén BO. Mplus User's Guide. 5th ed. Los Angeles, CA: Muthén & Muthén; 1998-2007.
25. Bryk AS, Raudenbush SW. Hierarchical Linear Models: Applications and Data Analysis Methods. Park, CA: Sage Publications Newbury; 1992.
26. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41.
27. Zimmerman M, Mattia JI. Psychiatric diagnosis in clinical practice: is comorbidity being missed? Compr Psychiatry 1999;40:182-191.